By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Weebit Nano and DB HiTek to demonstratechips integrating Weebit ReRAM at PCIM 2025
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Tech

Weebit Nano and DB HiTek to demonstratechips integrating Weebit ReRAM at PCIM 2025

GlobeNews Wire
Last updated: 01/05/2025 5:54 AM
GlobeNews Wire
Share
5 Min Read
Weebit Nano and DB HiTek to demonstratechips integrating Weebit ReRAM at PCIM 2025
SHARE
Weebit Nano and DB HiTek to demonstratechips integrating Weebit ReRAM at PCIM 2025

HOD HASHARON, Israel and SEOUL, South Korea, April 30, 2025 (GLOBE NEWSWIRE) — Weebit Nano Limited (ASX:WBT) (Weebit), a leading developer and licensor of advanced memory technologies for the global semiconductor industry, and tier-1 semiconductor foundry DB HiTek will show the first demonstration of DB HiTek’s Bipolar-CMOS-DMOS (BCD) silicon integrating Weebit’s Resistive Random-Access Memory (ReRAM) non-volatile memory (NVM) technology at PCIM 2025. PCIM is Europe’s largest power semiconductor exhibition, being held in Nuremberg, Germany, from May 6-8, 2025.

This is the latest step in the continued collaboration between the companies as they progress towards full qualification of Weebit’s embedded ReRAM module in DB HiTek’s 130nm BCD process, expected later this year. This process is ideal for analog, mixed-signal and high-voltage designs in consumer, industrial, IoT, and a range of other applications. Weebit ReRAM IP provides a high-density, low-power embedded NVM for these applications that is cost effective and has proven excellent retention at high temperatures.

The edge AI demonstration, running on DB HiTek chips with embedded Weebit ReRAM, shows an application of gesture recognition. It was developed in collaboration with Nanoveu’s (ASX: NVU) Embedded AI Systems Pte. Ltd. (EMASS) and will be shown in DB HiTek’s booth 680 in Hall 7 at PCIM.

Coby Hanoch, CEO of Weebit Nano, said: “Our collaboration with DB HiTek, one of the world’s leading foundries for mixed-signal and power integrated circuits, continues strongly and we are advancing steadily towards making our ReRAM IP available for production in its 130nm BCD process. This demo will provide a first look at the integrated technology and show the advantages of integrating ReRAM on-chip.”

Ki-Seog Cho, CEO, DB HiTek, said: “Weebit ReRAM provides a cost-effective and high-density non-volatile memory in our 130nm BCD process. We look forward to demonstrating the advantages of this innovative embedded IP to designers at PCIM. PCIM is a key show for DB HiTek as we expand our footprint in the growing European market, and we are delighted that Weebit will join us in our booth to highlight our integrated solution.”

Weebit ReRAM will be qualified in DB HiTek’s BCD 130nm process and ready for production in calendar 2025. Once qualified, DB HiTek will add Weebit’s memory module to its BCD 130nm Process Design Kit (PDK). DB HiTek customers can use the standard 1Mb modules in the PDK or have modules customized for their needs. Weebit ReRAM is available now to select DB HiTek customers for design prototyping.

About DB HiTek

Headquartered in South Korea, DB HiTek Co., Ltd. is world leader in specialty foundry with a broad range of support services plus a robust portfolio of competitive process technologies that include Analog/Power (BCDMOS), CMOS Image Sensor (CIS), Mixed-Signal, High Voltage CMOS, RF HRS/SOI CMOS, Super Junction MOSFET technologies. For more information, visit www.dbhitek.com.

About Weebit Nano Limited

Weebit Nano Ltd. is a leading developer and licensor of advanced semiconductor memory technology. The company’s ground-breaking Resistive RAM (ReRAM) non-volatile memory (NVM) addresses the growing need for significantly higher performance and lower power memory solutions in a range of electronic products such as AI, Internet of Things (IoT) and wearable devices, automotive, industrial automation, robotics, neuromorphic computing, and many others. For these applications, Weebit ReRAM allows semiconductor memory elements to be significantly faster, less expensive, more reliable and more energy efficient than those using existing flash memory solutions. As it is based on fab-friendly materials, the technology can be quickly and easily integrated with existing flows and processes, without the need for special equipment or large investments. See www.weebit-nano.com.

Weebit Nano and the Weebit Nano logo are trademarks or registered trademarks of Weebit Nano Ltd. in the United States and other countries. Other company, product, and service names may be trademarks or service marks of others.

Media – US
Jen Bernier-Santarini, Weebit Nano
P: +1 650-336-4222
E: jen@weebit-nano.com

Media – Australia
Dylan Mark, Automic Group
P: +61 475 783 675
E: dylan.mark@automicgroup.com.au

Investors
Danny Younis, Automic Group
P: +61 420 293 042
E: danny.younis@automicgroup.com.au

You Might Also Like

Hyundai Motor Group Unveils Nextgeneration Hybrid System, Delivering a New Standard in Power and Efficiency

ICON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against ICON plc – ICLR

XRP News: As Ripples Price Eyes Breakout, $XRT Surges 150% Launches Liquid Staking On XRPL

GEP PLACED IN THE LEADERS QUADRANT IN GARTNER 2025 MAGIC QUADRANT FOR SOURCE-TO-PAY SUITES

Hisense Unveils Groundbreaking TV Innovation at CES 2025 Delivering Audio-Visual Excellence in Collaboration with Pantone and Devialet

TAGGED:applicationsaprilasxwbtAU000000WBT5AUST:WBT.AXbcdcollaborationdemonstrationdeveloperembeddedglobehasharonhitekhitekshodisraelkorealeadinglimitedmemorynanonewswirenvmpcimprocessreramsemiconductorseoulsouthweebitweebitswill

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Scuderia Ferrari and HP Fuse Technology and Design with Special Livery for Miami Grand Prix Scuderia Ferrari and HP Fuse Technology and Design with Special Livery for Miami Grand Prix
Next Article Union Bank of India Launches MSME & CASA Outreach Programs to pass on benefits of back-to-back RBI-MPC rate cuts and Deepen Customer Engagement Union Bank of India Launches MSME & CASA Outreach Programs to pass on benefits of back-to-back RBI-MPC rate cuts and Deepen Customer Engagement

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

AVEROA receives European marketing authorization for XOANACYL, an Oral Therapy for Chronic Kidney Disease (CKD)
AVEROA receives European marketing authorization for XOANACYL, an Oral Therapy for Chronic Kidney Disease (CKD)
Health 16/06/2025
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope
Health 16/06/2025
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
Health 16/06/2025
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
Health 16/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?